###begin article-title 0
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
A novel VSX1 mutation identified in an individual with keratoconus in India
###end article-title 0
###begin p 1
The first two authors contributed equally to the manuscript
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
To evaluate the possible role of the VSX1 gene in a group of patients from the Indian subcontinent with keratoconus.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Molecular analysis of 66 patients with a diagnosis of keratoconus, based on clinical examination and corneal topography, was carried out. DNA extraction from peripheral blood followed by Polymerase Chain Reaction (PCR) amplification of the VSX1 gene was performed. The entire coding region and the exon-intron junctions of the VSX1 gene were analyzed by direct sequencing.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 217 225 <span type="species:ncbi:9606">patients</span>
A novel change at c.525G>C, replacing amino acid glutamine at position 175 with histidine, was found in one affected individual. One of the previously reported SNPs (rs12480307) was found with equal frequency in both patients and controls.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
This is the first report from the Indian subcontinent exploring the role of VSX1 in the causation of keratoconus. One novel mutation (Q175H) predicted to be a potentially damaging change was seen in an affected individual; this substantiates the importance of this gene but its precise role in disease causation needs further investigation.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
Keratoconus is a bilateral, noninflammatory, gradually progressive corneal disorder characterized by progressive thinning and steepening of the central cornea. It usually appears during teenage years, the common symptoms being myopia and astigmatism, and it is one of the major indications for corneal transplantation [1,2].
###end p 11
###begin p 12
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
Keratoconus normally occurs as a sporadic disorder, but both genetic and environmental factors seem to play a role in its causation [3]. A strong family history has been documented in about 6%-10% of patients with both autosomal and X-linked mode of inheritance [4,5]. Its prevalence in first-degree relatives is 13.5% [6] which is between 15 and 64 times higher than for the general population [7]. The etiology of keratoconus is unknown. It arises as an isolated defect but is also known to be associated with conditions such as Ehler-Danlos, Marfan, Apert, Noonan, and Downs Syndrome.
###end p 12
###begin p 13
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AIPL1</italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRB1</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRX</italic>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
Genome-wide linkage analyses have identified several chromosomal loci and genes that may be associated with keratoconus [8-12]; however, some were eventually excluded [13,14] while for others a conclusive association with the disease is yet to be established. Mutations in AIPL1, CRB1, and CRX have been implicated in patients with Leber congenital amaurosis, rendering them susceptible to keratoconus [15,16].
###end p 13
###begin p 14
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 641 645 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 482 487 <span type="species:ncbi:9606">human</span>
One of the strongly implicated candidate genes for keratoconus is Visual System Homeobox 1 (VSX1) localized to 20p11-q11. Initially this gene was chosen for screening mutations exploring the association between posterior polymorphous corneal dystrophy (PPCD) and keratoconus [12]. VSX1 is a developmental gene considered important in ocular development and is normally expressed in the developing cornea. VSX1 mRNA has been found in the outer tier of the inner nuclear layer of the human retina, embryonic craniofacial tissue and the cornea [17]. The gene has 5 exons spanning 6.2 kb of coding sequence [12]. Several genetic variants of the VSX1 gene [12,18-23] have been reported from various parts of the world but a definite pathogenic role of the genetic variants in causation of keratoconus is not yet established.
###end p 14
###begin p 15
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> VSXI</italic>
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 989 991 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 793 801 <span type="species:ncbi:9606">patients</span>
###xml 1054 1062 <span type="species:ncbi:9606">patients</span>
The VSXI variants include D144E, G160D, P247R, L159M, R166W, H244R, L17P, G160V and N151S (Table 1) which were initially reported as pathogenic but whose pathogenicity could not be confirmed because segregation of these variants was seen in unaffected individuals also. He on et al. [12] identified a compound heterozygous change with P247R and G160D and reported G160D to be pathogenic and P247R to be nonpathogenic. Another study [18] reported just the opposite, where P247R was found to be co-segregating with keratoconus. The D144E mutation was reported as pathogenic [18,22] in earlier studies but subsequent studies identified its presence in unaffected individuals and suggested this to be a polymorphism [19,20]. The variants R166W, H244R and L159M have been identified in keratoconus patients but these changes did not segregate with the disease phenotype in their family members and hence were not considered sufficiently significant to support a pathogenic role in keratoconus [21]. Similarly, variants G160V and N151S have been identified in patients from the Korean population [23] but these changes have not been reported from other populations.
###end p 15
###begin title 16
Summary of the sequence variants identified in various studies to date.
###end title 16
###begin p 17
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
###xml 381 389 <span type="species:ncbi:9606">patients</span>
Table 1 shows the sequence variants identified by various authors and the conclusions reached regarding their pathogenecity. 'F' represents families, 'Kc' represents patients with keratoconus, 'G' represents patients with glaucoma,' A' represents variants identified in patients affected with keratoconus, 'UA' represents variants identified in unaffected relatives of keratoconus patients, 'C' represents variants identified in controls and 'NVI' represents no variants identified.
###end p 17
###begin p 18
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
The present study was undertaken in order to search for genetic variations of the VSX1 gene in the Indian population and to explore its role in causation of keratoconus. Mutational analysis of VSX1 was carried out in 66 unrelated Indian patients affected with keratoconus in comparison to 100 controls.
###end p 18
###begin title 19
Methods
###end title 19
###begin p 20
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
###xml 712 720 <span type="species:ncbi:9606">patients</span>
Patients affected with keratoconus seen in the Cornea and Refractive Surgeries Services and Contact Lens Clinic at Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, during the period of March 2007 to 2008 were included in the study. The study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Ethics Committee. Informed consent was taken from all the patients before being enrolled for the present study. Detailed family histories up to three generations were taken and pedigree charts were constructed. History of ocular or other hereditary disorders was recorded. The existence of consanguinity and the regional birthplace of patients were also noted.
###end p 20
###begin p 21
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
###xml 857 865 <span type="species:ncbi:9606">patients</span>
A total of 66 unrelated patients with keratoconus were recruited in the present study: 23 females and 43 males, with 41 patients (62%) aged between 10 and 20. The patients presented with deterioration of vision and were diagnosed based on clinical features, such as stromal thinning, Vogt's striae, Fleischer's ring, Munson's sign, and corneal topography. Topographical features, such as corneal power (K), inferior-superior dioptric asymmetry (I-S), astigmatism (Ast), and skewed radial axis (SRAX) were used to calculate KISA% (a single index that quantifies the irregularity of corneal shape and presence of astigmatism, typical of keratoconus, with good clinical correlation). A total of 100 healthy volunteers with no ocular or other disorders matched for age and gender formed the controls. A peripheral blood sample (5 ml) was collected from all the patients and control subjects after taking informed consent and explaining the nature and possible consequences of study participation.
###end p 21
###begin title 22
DNA extraction and PCR amplification
###end title 22
###begin p 23
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 333 334 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Genomic DNA was extracted from peripheral blood leukocytes using standard protocols. All the five exons and intron/exon boundaries of VSX1 were amplified using custom-synthesized oligonucleotide primers as described previously [12]. Each reaction was carried out in a 25 mul mixture containing 2.5 mul 10X PCR buffer with 3.5 mM MgCl2, 2.5 mM dNTPs, 10 pM of each primer, 0.7 U Taq DNA polymerase (Roche) and 100 ng genomic DNA. Thermal cycling was performed in a thermal cycler (Applied Biosystem 9700) as described: initial denaturation for 12 min at 95 degreesC; 35 cycles at 94 degreesC for 30 s, 62 degreesC (exons 1-4) or 60 degreesC (exon 5) for 30 s, 72 degreesC for 30 s, and a final extension for 10 min at 72 degreesC.
###end p 23
###begin title 24
DNA Sequencing
###end title 24
###begin p 25
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
All the amplified products were sequenced bidirectionally using BigDye Terminator Mix version 3.1 (Applied Biosystems [ABI], Foster City, CA) according to the manufacturer's instructions and were analyzed on an ABI-3100 Genetic Analyzer (ABI). Nucleotide sequences were compared with the published VSX1 cDNA sequence (GenBank ).
###end p 25
###begin title 26
SIFT and PolyPhen analysis
###end title 26
###begin p 27
The potential impact of the amino acid change was assessed with the SIFT analysis tool (Sorting Intolerant From Tolerant) and PolyPhen analysis. These tools produce a multiple sequence alignment from different species of a gene to assess the positions of conserved amino acids and analyze the effect of missense changes on the conserved structure of proteins. The SIFT tool assigns a score to the mutations and a score of <0.05 is considered potentially damaging. PolyPhen analysis uses PSIC software (Position-Specific Independent Counts) to calculate profile scores (PSIC scores) that are logarithmic ratios of the likelihood of a given amino acid occurring at a particular position to the likelihood of this amino acid occurring at any position (background frequency).
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 451 459 451 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 850 858 850 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 154 162 <span type="species:ncbi:9606">patients</span>
###xml 248 256 <span type="species:ncbi:9606">patients</span>
###xml 916 924 <span type="species:ncbi:9606">patients</span>
The mean age at onset of symptoms among the patients was 18 years. Consanguinity was not present in any of the cases recruited for the present study. The patients were analyzed for the presence of mutations in all the five exons of VSX1. Among the patients under study a novel heterozygous nucleotide change c.525G>C (Q175H; GenBank ; ) was identified in one individual. The presence of this change was confirmed by a repeat bidirectional sequencing (Figure 1). No similar change was found in any of the 100 normal controls studied. SIFT tool analysis revealed a score of <0.05 and PolyPhen analysis gave a PSIC score difference of 1.896; both tools predicted that the replaced amino acid would be potentially damaging and would not be tolerated. The amino acid glutamine at position 175 is important and has been conserved throughout the orthologs (Figure 2). A previously reported SNP  was also identified in four patients and six controls, segregating with equal frequency in both groups.
###end p 29
###begin p 30
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 42 44 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">. </italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 141 148 <span type="species:ncbi:9606">patient</span>
###xml 262 269 <span type="species:ncbi:9606">patient</span>
Partial nucleotide sequence of VSX1 exon 3. Partial exon 3 nucleotide sequence of VSX1 showing G-->C transition in the mutated allele of the patient (P) in comparison to control (C). RP represents a partial chromatogram of the reverse nucleotide sequence of the patient in comparison to control (RC). The arrow-head shows the position of the change in the given sequences.
###end p 30
###begin p 31
Multiple sequence alignment of the amino acid sequences of VSX1 in different species. The highlighted amino acid glutamine (Q) shown in red at position 175 is conserved in all the orthologs.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 718 725 718 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 968 972 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 1060 1068 <span type="species:ncbi:9606">patients</span>
In the present study we identified a novel heterozygous change c.525G>C (Q175H; GenBank ; ) in an affected individual. SIFT tool and PolyPhen analyses predicted that the mutation Q175H (replacing amino acid glutamine with histidine) could be damaging. The absence of this change in 100 controls is suggestive of it being pathogenic. VSX1 has previously been implicated in causation of keratoconus according to earlier reports; these established that keratoconus and posterior polymorphic corneal dystrophy are co-localized within the chromosome 20p11-q11 region [12] and identified four sequence variants, two of which were considered pathogenic. To date, several genetic variants of the VSX1 gene have been reported (Table 1) but their pathogenicity could not always be confirmed because segregation of these variants was also seen in some unaffected individuals. Q175H is a novel mutation, identified in the present study, adding to the database of mutations in the VSX1 gene and supporting its role in keratoconus. However, its presence in just 1.6% of the patients proves that this may be a minor gene and its exact role during development needs to be documented.
###end p 33
###begin p 34
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 924 928 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 1079 1083 1079 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRB1</italic>
###xml 1228 1232 1228 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRB1</italic>
###xml 1307 1309 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1327 1331 1327 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 1059 1067 <span type="species:ncbi:9606">patients</span>
###xml 1142 1150 <span type="species:ncbi:9606">patients</span>
###xml 1254 1262 <span type="species:ncbi:9606">patients</span>
VSX1 expression is detected in adult retinal and corneal tissue and in embryonic craniofacial tissue [24,25]. The gene is a member of the CVC domain containing a paired-like class of homeodomains (HD) which play a role in craniofacial and ocular development [26]. The homeodomain region folds into three alpha helices; the latter two bind DNA in the major groove of the double helix and the third is the recognition helix that is responsible for amino acids making contact with the DNA bases. The Q175H change is present in the HD region of VSX1, where a neutral amino acid is replaced by a polar one. This may affect the binding of VSX1 protein with the DNA and modify the transcription rate. The onset for keratoconus is typically seen around the teenage years and so its role in normal eye development cannot be ruled out. In the light of previous studies, there is still insufficient evidence for the pathogenic role of VSX1 alone in causation of keratoconus. However, in our study potentially damaging mutation was detected, although only in 1.6% of the patients. Recently, CRB1 mutations were found to be associated with keratoconus in patients with Leber Congenital Amaurosis; in this case the authors suggested that the CRB1 mutations could make patients more susceptible to developing keratoconus [15]. Therefore, the VSX1 gene might have a small effect by itself, yet operate in conjunction with other genes or environmental factors in causation of keratoconus.
###end p 34
###begin p 35
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VSX1</italic>
To conclude, to the best of our knowledge this is the first report from the Indian subcontinent exploring the causative role of the VSX1 gene in keratoconus. We have identified one novel mutation, Q175H, predicted to cause a pathogenic change which would not be tolerated. This study adds one novel pathogenic mutation to the existing repertoire of VSX1 mutations but its wider role still needs to be explored.
###end p 35
###begin title 36
Acknowledgments
###end title 36
###begin p 37
###xml 27 35 <span type="species:ncbi:9606">patients</span>
We would like to thank the patients and their families for participating in the study and Professor Jaya Tyagi, Department of Biotechnology, All India Institute of Medical Sciences for the help and support provided. The study was supported by an intramural grant by the All India Institute of Medical Sciences (AIIMS). Preeti Paliwal is a recipient of Senior Research Fellowship (SRF) from the Council of Scientific and Industrial Research (CSIR), India. Anuradha Singh has been supported by a grant from the Department of Biotechnology (DBT), India.
###end p 37
###begin title 38
References
###end title 38
###begin article-title 39
Trends in the indications for penetrating keratoplasty, 1980-2001.
###end article-title 39
###begin article-title 40
Indications for penetrating keratoplasty and associated procedures, 1996-2000.
###end article-title 40
###begin article-title 41
The genetics of keratoconus.
###end article-title 41
###begin article-title 42
Keratoconus.
###end article-title 42
###begin article-title 43
Accuracy of videokeratographic quantitative criteria for detection of keratoconus suspects in families with keratoconus.
###end article-title 43
###begin article-title 44
Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.
###end article-title 44
###begin article-title 45
The genetics of keratoconus.
###end article-title 45
###begin article-title 46
A locus for autosomal dominant keratoconus: linkage to 16q22.3-q23.1 in Finnish families.
###end article-title 46
###begin article-title 47
###xml 51 56 <span type="species:ncbi:9606">human</span>
A locus for autosomal dominant keratoconus maps to human chromosome 3p14-q13.
###end article-title 47
###begin article-title 48
Genomewide linkage scan in a multigeneration Caucasian pedigree identifies a novel locus for keratoconus on chromosome 5q14.3-q21.1.
###end article-title 48
###begin article-title 49
Familial keratoconus with cataract: linkage to the long arm of chromosome 15 and exclusion of candidate genes.
###end article-title 49
###begin article-title 50
VSX1: a gene for posterior polymorphous dystrophy and keratoconus.
###end article-title 50
###begin article-title 51
Molecular genetic analysis in autosomal dominant keratoconus.
###end article-title 51
###begin article-title 52
Identity-by-descent approach to gene localisation in eight individuals affected by keratoconus from north-west Tasmania, Australia.
###end article-title 52
###begin article-title 53
###xml 55 63 <span type="species:ncbi:9606">Patients</span>
CRB1 Gene Mutations Are Associated with Keratoconus in Patients with Leber Congenital Amaurosis.
###end article-title 53
###begin article-title 54
###xml 46 54 <span type="species:ncbi:9606">patients</span>
The phenotype of Lebercongenital amaurosis in patients with AIPL1 mutations.
###end article-title 54
###begin article-title 55
RINX(VSX1), a novel homeobox gene expressed in the inner nuclear layer of the adult retina.
###end article-title 55
###begin article-title 56
###xml 48 56 <span type="species:ncbi:9606">patients</span>
VSX1 mutational analysis in a series of Italian patients affected by keratoconus: detection of a novel mutation.
###end article-title 56
###begin article-title 57
No VSX1 gene mutations associated with keratoconus.
###end article-title 57
###begin article-title 58
Molecular analysis of the VSX1 gene in familial keratoconus.
###end article-title 58
###begin article-title 59
Three VSX1 gene mutations, L159M, R166W, and H244R, are not associated with keratoconus.
###end article-title 59
###begin article-title 60
The D144E substitution in the VSX1 gene: a non-pathogenic variant or a disease causing mutation.
###end article-title 60
###begin article-title 61
###xml 71 79 <span type="species:ncbi:9606">patients</span>
VSX1 gene variants are associated with keratoconus in unrelated Korean patients.
###end article-title 61
###begin article-title 62
Expression of rinx/vsx1 during postnatal eye development in cone-bipolar, differentiating ganglion, and lens fiber cells.
###end article-title 62
###begin article-title 63
RINX(VSX1), a novel homeobox gene expressed in the inner nuclear layer of the adult retina.
###end article-title 63

